Research Article
Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
Table 5
Comparison of concentrations of MMP-3, MMP-9, and TIMP-1 in serum and AH of healthy individuals (controls) and diabetic patients with different stages of DR.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: healthy controls; 2: non-apparent DR; 3: mild/moderate NPDR; 4: advanced NPDR/PDR. Significant results after the Holm correction are displayed in bold. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||